Related Experiment Video

Updated: Jun 22, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

Persistent low albumin and temporary vascular access in pediatric patients with SLE on hemodialysis

Sangeeta D Sule1, Jeffrey J Fadrowski, Barbara A Fivush

  • 1School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA. ssule@jhmi.edu

Pediatric Nephrology (Berlin, Germany)
|June 16, 2009
PubMed

Insights

Pediatric patients with Systemic Lupus Erythematosus (SLE) on hemodialysis (HD) show persistent low albumin and less vascular access compared to other pediatric ESRD patients. These disparities remain over time, indicating ongoing challenges for SLE patients on HD.

Area of Science:

  • Nephrology
  • Pediatric Rheumatology
  • Clinical Outcomes Research

Background:

  • Systemic Lupus Erythematosus (SLE) frequently impacts pediatric kidneys, leading to end-stage renal disease (ESRD).
  • Previous research indicated lower serum albumin and less permanent vascular access in pediatric SLE patients with ESRD compared to other causes.

Purpose of the Study:

  • To longitudinally assess the achievement of clinical targets in pediatric patients with ESRD secondary to SLE.
  • To compare these targets over time between pediatric SLE patients and those with other ESRD etiologies undergoing hemodialysis (HD).

Main Methods:

  • Longitudinal analysis of pediatric patients from the ESRD Clinical Performance Measures Project (2000-2004).
  • Comparison of clinical target achievement (serum albumin, vascular access) between pediatric SLE-ESRD and non-SLE-ESRD groups on HD.

Main Results:

  • Pediatric SLE patients on HD were significantly less likely to achieve target albumin levels (OR 0.18; 95% CI 0.09-0.35).
  • These patients also had reduced likelihood of having arteriovenous fistulas or grafts (OR 0.45; 95% CI 0.23-0.89).
  • These disparities persisted throughout the follow-up period.

Conclusions:

  • Pediatric patients with SLE-associated ESRD on HD face persistent challenges in meeting key clinical targets.
  • These findings highlight a high-risk group requiring focused attention to improve long-term outcomes.
  • Continued monitoring and intervention are crucial for optimizing care in this vulnerable population.

Related Concept Videos

Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...